What's the Cost of Breast cancer Diagnosis and Treatment in India?
| India | Turkey | Austria | |
|---|---|---|---|
| Tomotherapy | ≈ $4,500 | from $8,400 | ≈ $9,500 |
| Resveratrol IV Therapy | ≈ $150 | ≈ $120 | ≈ $250 |
| Radiotherapy for breast cancer | ≈ $3,800 | from $4,000 | from $6,600 |
| Radiation therapy for colorectal cancer | ≈ $4,500 | from $6,000 | from $6,600 |
| Proton therapy for breast cancer | ≈ $22,000 | ≈ $28,000 | ≈ $24,000 |
Your Benefits and Guarantees with Bookimed
Transparent Prices & Flexible Installments
No hidden fees – just official clinic prices. Pay at the clinic for Breast cancer treatment and use a flexible installment plan if needed.
Verified Clinics & Doctors Only
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Breast cancer treatment and have the necessary licenses to serve international patients worldwide.
Free 24/7 Assistance
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Breast cancer treatment journey.

Your personal Bookimed medical coordinator
- Supports you at every stage
- Helps choose the right clinic and doctor
- Ensures quick and convenient access to information
Best Breast cancer Treatment Centers in India: 22 Verified Options and Prices
Apollo Hospital Indraprastha
Sidharth Sahni






Get a Medical Assessment for Breast cancer Treatment in India: Consult with 23 Experienced Doctors Now
View all Doctors
Sidharth Sahni
Dr. Sidharth Sahni specializes in breast cancer surgery with 19 years of experience, serving as a specialist breast surgeon to multiple embassies.
- Certified tutor at the Royal College of Surgeons in Edinburgh
- Member of the European Society of Mastology (EUSOMA)
- Specialist breast surgeon to the American, Russian, Israeli, Italian Embassies, and Australian High Commission
- Invited speaker at national and international scientific conferences
- Participated in international clinical trials

Anshuman Kumar
Dr. Anshuman Kumar is an oncologist at Fortis Gurgaon in India. He performs breast cancer treatments, including mastectomy and lumpectomy procedures. Dr. Kumar works at a facility named among the World's Best Smart Hospitals by Newsweek.
The clinic treats 3,500 patients annually and has 1,000 beds. This high-volume environment supports cancer care across multiple surgical disciplines. Dr. Kumar performs surgical interventions for breast cancer patients within this medical center.
Ranjita Pawar
Dr. Ranjita Pawar is the Director and Psychologist at ZorbaCare in Pune. She specializes in addiction recovery, family therapy, and adolescent mental health. Dr. Pawar holds a PhD in Psychology and an MSc in Applied Psychology from NMIMS, Mumbai. She leads the psychotherapy programs at ZorbaCare, an ISO 9001:2015 certified facility.
- Treats alcohol, drug, and opioid use disorders.
- Treats mental health conditions such as anxiety and depression that occur during recovery.
- Conducts family therapy sessions to improve communication and prevent relapse.
- Directs a team at a clinic serving patients across Mumbai and Pune.

Dr. Vedant Kabra
Dr. Vedant Kabra is a leading oncosurgeon and the Head of the Department of Oncological Surgery at Fortis Gurgaon.
- Specializes exclusively in surgical oncology
- Leads a dedicated cancer surgery department
- Focuses on breast cancer cases
Reviews about Bookimed: Discover Patients' Insights
All reviewsRelated Articles
View more
Breast cancer detection
Written by Veronika Kazina

Breast cancer: symptoms, causes, and prevention
Written by Veronika Kazina

Types of breast cancer
Written by Veronika Kazina

Breast examination. Interview with the famous professor. Part 1
Written by Veronika Kazina

Organ-preserving surgeries for breast cancer treatment in Israel
Written by Veronika Kazina
Share this content
Video Stories from Bookimed Patients
Anna Leonova
Expert Overview about Breast cancer Treatment in India
What are the primary treatment options available for breast cancer in India?
India provides multi-modal breast cancer treatment using international protocols. Primary options include breast-conserving surgery, modified radical mastectomy, and sentinel lymph node biopsy. JCI-accredited centers also offer targeted therapies like Herzuma and advanced radiation techniques including IMRT and IGRT to preserve healthy tissue.
- Surgical interventions: Surgeons perform lumpectomies or full mastectomies based on tumor size and stage.
- Advanced diagnostics: Facilities use IBM Watson oncology software to select personalized chemotherapy and hormone protocols.
- Expert surgical volume: Specialists like Dr. Raj Nagarkar have performed over 50,000 successful cancer surgeries.
- Systemic therapy: Options include neoadjuvant chemotherapy to shrink tumors and HER2-specific targeted immunotherapy.
Bookimed Expert Insight: Patient volume often dictates specialized expertise in India. HCG Manavata Cancer Centre and Apollo Hospital Indraprastha handle massive caseloads, with doctors often performing twice the annual surgeries of Western counterparts. This high repetition contributes to high success rates in complex breast reconstructions and robotic-assisted tumor removals.
Patient Consensus: Patients note that medical care is high quality, but having an English-speaking companion helps manage hospital logistics. Using Indian-manufactured generic medications and biosimilars significantly reduces the total cost of chemotherapy and hormone treatments.
What is the success rate for breast cancer treatment in India?
The national five-year survival rate for breast cancer in India is approximately 66.4%. Success rates reach 90% to 95% when the disease is caught at Stage I. Leading JCI-accredited hospitals in Delhi, Mumbai, and Bengaluru offer clinical outcomes comparable to Western medical standards.
- Stage I survival: Early detection offers a 90% to 95% five-year survival rate.
- Stage II survival: Localized cancer correlates with success rates between 78% and 92%.
- Advanced stage outcomes: Survival for Stage III cases ranges from 57% to 70%.
- Expert surgical volume: Dr. Raj Nagarkar has performed over 50,000 successful cancer surgeries.
Bookimed Expert Insight: Patient volume is a major success driver in India. Manipal Hospitals serves 2,000,000 patients annually, while Apollo hospitals treat over 1,000,000 people. This massive caseload allows surgeons like Dr. Surender Dabas to perform 8,000+ specialized procedures. High repetition leads to technical mastery that often mirrors or exceeds global survival benchmarks.
Patient Consensus: Patients emphasize that catching a tumor under 3 cm is vital for the best results. Many note that high-quality care at private centers feels identical to Western hospitals but at a lower cost.
Does treatment affect fertility?
Breast cancer treatments like chemotherapy and hormone therapy frequently impact fertility by damaging ovaries or suppressing ovulation. Chemotherapy drugs, especially alkylating agents, can cause permanent ovarian failure. Hormone blockers like tamoxifen typically require five to ten years of use, during which pregnancy is contraindicated.
- Chemotherapy risk: Drugs may cause permanent infertility or premature menopause in women.
- Hormonal suppression: Tamoxifen and aromatase inhibitors suppress ovulation during the five-year treatment course.
- Fertility preservation: Egg or embryo freezing is recommended before starting neoadjuvant chemotherapy protocols.
- Surgical impact: While mastectomy preserves reproductive organs, systemic treatments following surgery affect conception.
Bookimed Expert Insight: India offers a high density of specialized oncology expertise, with 1,900+ doctors at Manipal Hospitals and 800+ at Medanta. Data shows top-tier facilities like Apollo Hospital Indraprastha and BLK Super Speciality are JCI-accredited, ensuring international safety standards for fertility-sparing protocols. Choosing these high-volume centers is vital because they integrate oncological surgery with immediate fertility preservation services.
Patient Consensus: Patients note that menses may resume six to twelve months post-chemo, especially for those under 35. Many emphasize tracking AMH levels before starting any treatment to understand their reproductive baseline.
How do doctors decide between a lumpectomy and a mastectomy?
Doctors decide between lumpectomy and mastectomy by evaluating tumor size, cancer stage, and genetic risks like BRCA mutations. A lumpectomy preserves breast tissue but requires follow-up radiation. A mastectomy removes the entire breast. Indian oncology centers confirm both procedures offer equivalent long-term survival for early-stage cases.
- Tumor-to-breast ratio: Lumpectomy is preferred if surgeons can achieve clear margins while maintaining appearance.
- Cancer distribution: Mastectomy is necessary for multicentric disease or multiple tumors in one breast.
- Radiation access: Patients unable to undergo weeks of required daily radiation often require mastectomy.
- Genetic profile: High-risk mutations may lead doctors to recommend mastectomy to prevent future cancers.
Bookimed Expert Insight: Data from top Indian facilities like Manipal and HCG Manavata shows a high volume of breast-conserving surgeries. Dr. Raj Nagarkar has performed over 50,000 cancer surgeries, highlighting the deep expertise available. While private metros prioritize conservation, choosing a center with on-site radiation is vital. This ensures you can actually complete the lumpectomy protocol without travel delays.
Patient Consensus: Patients note it is important to ask about the tumor-to-breast ratio and radiation feasibility early. Many suggest pushing for oncoplastic surgeons in major cities like Delhi or Bengaluru to improve cosmetic results.
What are the chances of the cancer returning after treatment?
Breast cancer recurrence risk in India typically ranges from under 10% for Stage 1 to 50% for Stage 3. Success depends on the biological subtype and treatment adherence. Leading Indian centers utilize advanced surgery and hormonal therapies to minimize long-term risks for patients.
- Stage 1 risk: Recurrence rates are generally low, often staying below 10% after initial treatment.
- Stage 3 risk: Advanced cases carry a higher recurrence risk, typically between 30% and 50%.
- Hormonal therapy: Completing 5 to 10 years of therapy drastically reduces long-term return risks.
- Monitoring schedule: Regular screenings every 3 to 6 months catch early signs effectively.
Bookimed Expert Insight: High-volume surgeons in India, like Dr. Raj Nagarkar who has performed over 50,000 surgeries, emphasize that experience directly impacts clear margins. Data from facilities like Manipal Hospitals, serving 2,000,000 patients annually, suggest that integrated tumor boards help standardize aggressive protocols that lower recurrence in complex cases.
Patient Consensus: Patients emphasize that reaching no evidence of disease status is a major milestone but requires lifelong vigilance. Many note that reporting new bone pain or persistent headaches immediately to their oncologist is vital for early detection.
Which hospitals are recognized for specialized breast cancer care in India?
India offers specialized breast cancer care through JCI-accredited hospitals and dedicated oncology research institutes. Facilities like Apollo Hospital Indraprastha and Medanta provide advanced diagnostics and robotic surgery. Specialized centers like HCG and Tata Memorial focus on breast conservation and high-volume surgical expertise.
- Surgical expertise: Dr. Raj Nagarkar has performed over 50,000 cancer surgeries at HCG Manavata.
- Advanced radiotherapy: Apollo Proton Cancer Centre utilizes proton therapy to protect the heart and lungs.
- Robotic systems: Fortis Gurgaon and BLK Super Speciality employ Da Vinci technology for precision.
- Targeted diagnostics: Clinics use 3D tomosynthesis and vacuum-assisted biopsies for early, accurate detection.
Bookimed Expert Insight: Data shows that hospital volume and doctor specialization are the strongest quality signals in India. For instance, Dr. Sidharth Sahni at Apollo holds international certifications from the European Society of Mastology. Choosing surgeons with 20+ years of experience often ensures access to advanced techniques like oncoplastic reconstruction.
Patient Consensus: Patients emphasize finding a surgeon who specializes specifically in breast oncology rather than general surgery. They also note that having a medically literate companion is helpful for navigating complex hospital coordination and ensuring clear communication during consultations.
















